InvestorsHub Logo
Followers 22
Posts 3636
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Friday, 01/04/2019 4:54:58 PM

Friday, January 04, 2019 4:54:58 PM

Post# of 20689
Momenta Pharma slips 4% on JPMorgan downgrade - SEEKING ALPHA

Jan. 4, 2019 11:37 AM ET|About: Momenta Pharmaceutical... (MNTA)|By: Douglas W. House, SA News Editor

Momenta Pharmaceuticals (MNTA -3.6%) is down on lower-than-average volume following a downgrade to Neutral at JPMorgan. Analyst Eric Joseph trimmed his fair value target almost in half to $12 (16% upside) citing the long timelines for key assets.

Phase 2 data on M281 in myasthenia gravis, for example, won't be available until 2020.

https://seekingalpha.com/news/3420737-momenta-pharma-slips-4-percent-jpmorgan-downgrade